Iperion Life Sciences Consultancy will become Iperion – a Deloitte business from May 1.
Six years ago, we started Iperion with ambitions to boost innovation in Life Sciences by promoting the structuring and digitizing of regulated data required for the approval and monitoring of medicines. – not only to accelerate speed to market, but to enable greater global collaboration based on reliable, consistent and globally comparable information about medicinal products.
Looking back, we feel privileged to see how we have been able to influence change in Life Sciences.
Iperion Life Sciences IT-cloud will continue to operate as Colbright.